+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Infectious Disease Diagnostic Market by Product (Instruments, Reagents & Kits, Software), Sample Type (Blood, Stool, Swab), Technology, Testing Type, Disease Type, End-User - Global Forecast 2025-2030- Product Image
Infectious Disease Diagnostic Market by Product (Instruments, Reagents & Kits, Software), Sample Type (Blood, Stool, Swab), Technology, Testing Type, Disease Type, End-User - Global Forecast 2025-2030- Product Image
Sale

Infectious Disease Diagnostic Market by Product (Instruments, Reagents & Kits, Software), Sample Type (Blood, Stool, Swab), Technology, Testing Type, Disease Type, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 188 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4829907
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Infectious Disease Diagnostic Market is undergoing continuous change as innovation, operational realities, and regulatory dynamics reshape testing environments and industry collaboration. Senior executives need clear visibility into the interplay of market forces to optimize investment and future-proof strategy in this compelling sector.

Market Snapshot: Infectious Disease Diagnostic Market Overview

The global infectious disease diagnostic market grew from USD 31.27 billion in 2024 to USD 33.95 billion in 2025. With an expected compound annual growth rate (CAGR) of 8.82%, the market is projected to reach USD 51.96 billion by 2030. Market expansion is being driven by rapid technological advances, increased demand for timely and accurate pathogen detection, and evolving disease surveillance strategies globally. Stakeholders are navigating shifts in care delivery models, supply chains, and regulatory frameworks as the competitive landscape intensifies.

Scope & Segmentation: Strategic Landscape of Infectious Disease Diagnostics

This report provides comprehensive segmentation and strategic context, supporting decision-makers responsible for commercial, clinical, and R&D strategy. Key segmentation includes:

  • Product Categories: Instruments (immunoassay analyzers, mass spectrometers, microarrays, PCR systems), reagents & kits (antigen detection kits, ELISA kits, immunoassay kits, PCR kits), and supporting software solutions.
  • Sample Types: Blood (plasma, serum, whole blood), stool, swab (nasal, rectal, throat), and urine for diverse pathogen detection needs across clinical workflows.
  • Technology Modalities: Immunoassays, microbiology, molecular diagnostics, next-generation sequencing, integrated into layered testing frameworks.
  • Testing Environments: Laboratory-based diagnostics and point-of-care (PoC) testing supporting centralized and remote access.
  • Disease Categories: Bacterial, fungal, parasitic, vector-borne, and viral infectious diseases including various high-priority pathologies.
  • End-User Segments: Academic and research institutes, diagnostic laboratories, hospitals, and clinics.
  • Geographies: Detailed regional analysis includes Americas (e.g., United States, Canada, Brazil, Mexico), EMEA (including United Kingdom, Germany, France, Middle East, Africa), and Asia-Pacific (e.g., China, India, Japan, Australia, Southeast Asia).

Key Takeaways: Actionable Insights for Senior Decision-Makers

  • Technological convergence—blending molecular platforms, sequencing, and digital connectivity—is enabling a shift toward precision diagnostics and real-time pathogen surveillance.
  • Regulatory evolution is supporting quicker introduction of novel diagnostic tools, but laboratories and manufacturers must also manage increased operational complexities and workforce challenges.
  • Decentralized testing models are bridging gaps in clinical accessibility, requiring flexible technology adoption and new approaches to workforce training and quality assurance.
  • Cross-disciplinary collaboration across industry, academia, and public health organizations fosters scalable innovation and accelerates commercial deployment of research breakthroughs.
  • Integrated informatics platforms and software are becoming crucial for data management, compliance, and connected patient care across diverse testing environments.
  • Market heterogeneity demands tailored business strategies, with regional investment adapting to infrastructure maturity, local disease burdens, and public-private partnership levels.

Impact of US Tariffs on Supply Chains & Trade

The 2025 US tariff framework is prompting shifts in sourcing and supply chain resilience for diagnostic manufacturers relying on international reagents, consumables, and equipment. Companies are intensifying efforts to localize manufacturing and diversify supplier networks, mitigating the risk of pricing pressure and safeguarding clinical accessibility. Policy advocacy and industry partnerships are focused on maintaining open trade routes for essential diagnostic supplies amid changing fiscal environments.

Methodology & Data Sources

This research integrates primary interviews with senior industry leaders, laboratory directors, and regulatory experts, complemented by a review of peer-reviewed literature, healthcare agency reports, and regulatory filings. Data is validated through cross-referencing multiple sources and triangulation to ensure analytical rigor and current market relevance.

Why This Report Matters

  • Enables senior decision-makers to benchmark strategic priorities, identify emerging growth opportunities, and manage operational and regulatory risks effectively.
  • Delivers actionable market segmentation, unlocking insights across product, technology, and end-user dimensions to inform portfolio and go-to-market strategies.
  • Offers nuanced analysis of regional market dynamics and competitor strategies for informed investment and partnership decisions.

Conclusion

As infectious disease diagnostics evolve, stakeholders must align innovation, operational resilience, and collaboration to capture value and address global health needs. This analysis supports confident strategic planning amid shifting industry currents.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising need for rapid diagnostics for early detection of infectious diseases
5.2. Increasing demand for rapid antigen screening in airports and public venues enhancing community safety
5.3. Adoption of AI-driven predictive analytics optimizing outbreak surveillance and response strategies
5.4. Expansion of point-of-care multiplex assays driving decentralized infectious disease testing accessibility
5.5. Integration of CRISPR-based diagnostics streamlining rapid pathogen detection workflows
5.6. Expansion of telehealth-linked diagnostic platforms accelerating remote infectious disease management
5.7. Advancements in next-generation sequencing enabling comprehensive pathogen identification in clinical labs
5.8. Shift toward at-home molecular testing kits empowering patient-centric infectious disease monitoring
5.9. Genomic tools powering the new era of infection tracking
5.10. Implementation of digital biomarkers and wearable sensors to predict infection onset before symptoms
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Infectious Disease Diagnostic Market, by Product
8.1. Introduction
8.2. Instruments
8.2.1. Immunoassay Analyzers
8.2.2. Mass Spectrometers
8.2.3. Microarrays
8.2.4. PCR Systems
8.3. Reagents & Kits
8.3.1. Antigen Detection Kits
8.3.2. ELISA Kits
8.3.3. Immunoassay Kits
8.3.4. PCR Kits
8.4. Software
9. Infectious Disease Diagnostic Market, by Sample Type
9.1. Introduction
9.2. Blood
9.2.1. Plasma
9.2.2. Serum
9.2.3. Whole Blood
9.3. Stool
9.4. Swab
9.4.1. Nasal
9.4.2. Rectal
9.4.3. Throat
9.5. Urine
10. Infectious Disease Diagnostic Market, by Technology
10.1. Introduction
10.2. Immunoassays
10.3. Microbiology
10.4. Molecular Diagnostics
10.5. Next-Generation Sequencing
11. Infectious Disease Diagnostic Market, by Testing Type
11.1. Introduction
11.2. Laboratory Testing
11.3. PoC Testing
12. Infectious Disease Diagnostic Market, by Disease Type
12.1. Introduction
12.2. Bacterial Infectious Diseases
12.2.1. Meningitis
12.2.2. Pneumonia
12.2.3. Tuberculosis
12.3. Fungal Infections
12.3.1. Aspergillosis
12.3.2. Candidiasis
12.3.3. Cryptococcosis
12.4. Parasitic Infections
12.4.1. Leishmaniasis
12.4.2. Malaria
12.4.3. Schistosomiasis
12.5. Vector-borne Infections
12.5.1. Dengue Fever
12.5.2. Lyme Disease
12.5.3. Zika Virus
12.6. Viral Infectious Diseases
12.6.1. Hepatitis (A, B, C)
12.6.2. Hepatitis B & C
12.6.3. HIV/AIDS
12.6.4. Influenza
13. Infectious Disease Diagnostic Market, by End-User
13.1. Introduction
13.2. Academic & Research Institutes
13.3. Diagnostic Laboratories
13.4. Hospitals & Clinics
14. Americas Infectious Disease Diagnostic Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Infectious Disease Diagnostic Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Infectious Disease Diagnostic Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Abbott Laboratories
17.3.2. Adaptive Biotechnologies Corporation
17.3.3. Agilent Technologies, Inc.
17.3.4. Becton, Dickinson and Company
17.3.5. Bio-Rad Laboratories, Inc.
17.3.6. Bio-Techne Corporation
17.3.7. bioMérieux SA
17.3.8. Cardinal Health Inc.
17.3.9. Danaher Corporation
17.3.10. F. Hoffmann-La Roche Ltd.
17.3.11. GE HealthCare Technologies Inc.
17.3.12. Grifols, S.A.
17.3.13. Hologic Inc.
17.3.14. Illumina, Inc.
17.3.15. Johnson & Johnson Services, Inc.
17.3.16. Konica Minolta, Inc.
17.3.17. MedMira Inc.
17.3.18. Merck KGaA
17.3.19. Olympus Corporation
17.3.20. Perkin Elmer, Inc.
17.3.21. Pfizer Inc.
17.3.22. Qiagen N.V.
17.3.23. Quest Diagnostics Incorporated
17.3.24. Siemens Healthineers AG
17.3.25. Sysmex Corporation
17.3.26. Thermo Fisher Scientific, Inc.
17.3.27. Trivitron Healthcare
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. INFECTIOUS DISEASE DIAGNOSTIC MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 6. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY DISEASE TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY DISEASE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. INFECTIOUS DISEASE DIAGNOSTIC MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. INFECTIOUS DISEASE DIAGNOSTIC MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. INFECTIOUS DISEASE DIAGNOSTIC MARKET: RESEARCHAI
FIGURE 28. INFECTIOUS DISEASE DIAGNOSTIC MARKET: RESEARCHSTATISTICS
FIGURE 29. INFECTIOUS DISEASE DIAGNOSTIC MARKET: RESEARCHCONTACTS
FIGURE 30. INFECTIOUS DISEASE DIAGNOSTIC MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. INFECTIOUS DISEASE DIAGNOSTIC MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY IMMUNOASSAY ANALYZERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY IMMUNOASSAY ANALYZERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY MASS SPECTROMETERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY MASS SPECTROMETERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY MICROARRAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY MICROARRAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PCR SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PCR SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY ANTIGEN DETECTION KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY ANTIGEN DETECTION KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY ELISA KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY ELISA KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY IMMUNOASSAY KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY IMMUNOASSAY KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PCR KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PCR KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BLOOD, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BLOOD, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PLASMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PLASMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SERUM, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SERUM, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY STOOL, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY STOOL, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SWAB, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SWAB, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY NASAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY NASAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY RECTAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY RECTAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY THROAT, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY THROAT, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SWAB, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SWAB, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY URINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY URINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY POC TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY POC TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BACTERIAL INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BACTERIAL INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY MENINGITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY MENINGITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PNEUMONIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PNEUMONIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TUBERCULOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TUBERCULOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BACTERIAL INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BACTERIAL INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY FUNGAL INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY FUNGAL INFECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY ASPERGILLOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY ASPERGILLOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY CANDIDIASIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY CANDIDIASIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY CRYPTOCOCCOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY CRYPTOCOCCOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY FUNGAL INFECTIONS, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY FUNGAL INFECTIONS, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PARASITIC INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PARASITIC INFECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY LEISHMANIASIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY LEISHMANIASIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY MALARIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY MALARIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SCHISTOSOMIASIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SCHISTOSOMIASIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PARASITIC INFECTIONS, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VECTOR-BORNE INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VECTOR-BORNE INFECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY DENGUE FEVER, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY DENGUE FEVER, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY LYME DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY LYME DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY ZIKA VIRUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY ZIKA VIRUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VECTOR-BORNE INFECTIONS, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VECTOR-BORNE INFECTIONS, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VIRAL INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VIRAL INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY HEPATITIS (A, B, C), BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY HEPATITIS (A, B, C), BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY HEPATITIS B & C, BY REGION, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY HEPATITIS B & C, BY REGION, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY HIV/AIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY HIV/AIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY INFLUENZA, BY REGION, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY INFLUENZA, BY REGION, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VIRAL INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VIRAL INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 135. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 137. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 138. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 139. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 140. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SWAB, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SWAB, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 159. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BACTERIAL INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 160. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BACTERIAL INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 161. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY FUNGAL INFECTIONS, 2018-2024 (USD MILLION)
TABLE 162. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY FUNGAL INFECTIONS, 2025-2030 (USD MILLION)
TABLE 163. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2024 (USD MILLION)
TABLE 164. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PARASITIC INFECTIONS, 2025-2030 (USD MILLION)
TABLE 165. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VECTOR-BORNE INFECTIONS, 2018-2024 (USD MILLION)
TABLE 166. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VECTOR-BORNE INFECTIONS, 2025-2030 (USD MILLION)
TABLE 167. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VIRAL INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 168. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VIRAL INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 169. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 170. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 171. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 172. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SWAB, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SWAB, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BACTERIAL INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BACTERIAL INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 193. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY FUNGAL INFECTIONS, 2018-2024 (USD MILLION)
TABLE 194. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY FUNGAL INFECTIONS, 2025-2030 (USD MILLION)
TABLE 195. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2024 (USD MILLION)
TABLE 196. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PARASITIC INFECTIONS, 2025-2030 (USD MILLION)
TABLE 197. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VECTOR-BORNE INFECTIONS, 2018-2024 (USD MILLION)
TABLE 198. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VECTOR-BORNE INFECTIONS, 2025-2030 (USD MILLION)
TABLE 199. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VIRAL INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 200. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VIRAL INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 201. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 202. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 203. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 204. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 205. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 206. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 207. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 208. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 209. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2018-2024 (USD MILLION)
TABLE 210. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2025-2030 (USD MILLION)
TABLE 211. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 212. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 213. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 214. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 215. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SWAB, 2018-2024 (USD MILLION)
TABLE 216. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SWAB, 2025-2030 (USD MILLION)
TABLE 217. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 218. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 219. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
TABLE 220. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2025-2030 (USD MILLION)
TABLE 221. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 222. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 223. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BACTERIAL INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 224. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BACTERIAL INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 225. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY FUNGAL INFECTIONS, 2018-2024 (USD MILLION)
TABLE 226. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY FUNGAL INFECTIONS, 2025-2030 (USD MILLION)
TABLE 227. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2024 (USD MILLION)
TABLE 228. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PARASITIC INFECTIONS, 2025-2030 (USD MILLION)
TABLE 229. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VECTOR-BORNE INFECTIONS, 2018-2024 (USD MILLION)
TABLE 230. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VECTOR-BORNE INFECTIONS, 2025-2030 (USD MILLION)
TABLE 231. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VIRAL INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 232. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VIRAL INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 233. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 234. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 235. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 236. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 237. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 238. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 239. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2018-2024 (USD MILLION)
TABLE 240. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2025-2030 (USD MILLION)
TABLE 241. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 242. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 243. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 244. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 245. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SWAB, 2018-2024 (USD MILLION)
TABLE 246. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SWAB, 2025-2030 (USD MILLION)
TABLE 247. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 248. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 249. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
TABLE 250. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2025-2030 (USD MILLION)
TABLE 251. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 252. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 253. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BACTERIAL INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 254. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BACTERIAL INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 255. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY FUNGAL INFECTIONS, 2018-2024 (USD MILLION)
TABLE 256. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY FUNGAL INFECTIONS, 2025-2030 (USD MILLION)
TABLE 257. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2024 (USD MILLION)
TABLE 258. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PARASITIC INFECTIONS, 2025-2030 (USD MILLION)
TABLE 259. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VECTOR-BORNE INFECTIONS, 2018-2024 (USD MILLION)
TABLE 260. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VECTOR-BORNE INFECTIONS, 2025-2030 (USD MILLION)
TABLE 261. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VIRAL INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 262. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VIRAL INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 263. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 264. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 265. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 266. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 267. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 268. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 269. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2018-2024 (USD MILLION)
TABLE 270. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2025-2030 (USD MILLION)
TABLE 271. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 272. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 273. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 274. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 275. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SWAB, 2018-2024 (USD MILLION)
TABLE 276. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SWAB, 2025-2030 (USD MILLION)
TABLE 277. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 278. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 279. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
TABLE 280. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2025-2030 (USD MILLION)
TABLE 281. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 282. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 283. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BACTERIAL INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 284. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BACTERIAL INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 285. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY FUNGAL INFECTIONS, 2018-2024 (USD MILLION)
TABLE 286. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY FUNGAL INFECTIONS, 2025-2030 (USD MILLION)
TABLE 287. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2024 (USD MILLION)
TABLE 288. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PARASITIC INFECTIONS, 2025-2030 (USD MILLION)
TABLE 289. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VECTOR-BORNE INFECTIONS, 2018-2024 (USD MILLION)
TABLE 290. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VECTOR-BORNE INFECTIONS, 2025-2030 (USD MILLION)
TABLE 291. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VIRAL INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 292. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VIRAL INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 293. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 294. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 295. ARGENTINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 296. ARGENTINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 297. ARGENTINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 298. ARGENTINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 299. ARGENTINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2018-2024 (USD MILLION)
TABLE 300. ARGENTINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2025-2030 (USD MILLION)
TABLE 301. ARGENTINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 302. ARGENTINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 303. ARGENTINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 304. ARGENTINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 305. ARGENTINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SWAB, 2018-2024 (USD MILLION)
TABLE 306. AR

Samples

Loading
LOADING...

Companies Mentioned

  • Abbott Laboratories
  • Adaptive Biotechnologies Corporation
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • bioMérieux SA
  • Cardinal Health Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • GE HealthCare Technologies Inc.
  • Grifols, S.A.
  • Hologic Inc.
  • Illumina, Inc.
  • Johnson & Johnson Services, Inc.
  • Konica Minolta, Inc.
  • MedMira Inc.
  • Merck KGaA
  • Olympus Corporation
  • Perkin Elmer, Inc.
  • Pfizer Inc.
  • Qiagen N.V.
  • Quest Diagnostics Incorporated
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc.
  • Trivitron Healthcare

Table Information

Report AttributeDetails
No. of Pages188
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 33.95 Billion
Forecasted Market Value ( USD ) by 2030 $ 51.96 Billion
Compound Annual Growth Rate8.8%
Regions CoveredGlobal
No. of Companies Mentioned27

Related Topics

Related Reports

North America Infectious Disease Diagnostics Market Forecast to 2030 - Regional Analysis - By Product, Technology, Application Type, Testing Type, and End User - Product Image

North America Infectious Disease Diagnostics Market Forecast to 2030 - Regional Analysis - By Product, Technology, Application Type, Testing Type, and End User

  • Report
  • 115 Pages
  • North America
From
Asia Pacific Infectious Disease Diagnostics Market Forecast to 2030 - Regional Analysis - By Product, Technology, Application Type, Testing Type, and End User - Product Image

Asia Pacific Infectious Disease Diagnostics Market Forecast to 2030 - Regional Analysis - By Product, Technology, Application Type, Testing Type, and End User

  • Report
  • 136 Pages
  • Asia Pacific
From
Gastrointestinal Infection Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Gastrointestinal Infection Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 207 Pages
  • Global
From
Healthcare-associated Infectious Disease Diagnostics Market by Test Method (Immunoassays, Microbiology, Molecular Diagnostics), Pathogen Type (Bacterial, Fungal, Parasitic), End User, Sample Type - Global Forecast 2025-2030 - Product Image

Healthcare-associated Infectious Disease Diagnostics Market by Test Method (Immunoassays, Microbiology, Molecular Diagnostics), Pathogen Type (Bacterial, Fungal, Parasitic), End User, Sample Type - Global Forecast 2025-2030

  • Report
  • 197 Pages
  • Global
From
Infectious Diseases In-Vitro Diagnostics Market by Product (Instruments, Reagents & Kits, Software & Services), Technology (Immunoassays, Microbiology Culture, Molecular Diagnostics), Pathogen, Application, End User - Global Forecast 2025-2030 - Product Image

Infectious Diseases In-Vitro Diagnostics Market by Product (Instruments, Reagents & Kits, Software & Services), Technology (Immunoassays, Microbiology Culture, Molecular Diagnostics), Pathogen, Application, End User - Global Forecast 2025-2030

  • Report
  • 192 Pages
  • Global
From

About the Infectious Disease Testing Market

The Infectious Disease Testing market is a sector of the healthcare industry that focuses on the diagnosis and treatment of infectious diseases. It includes a range of tests, such as blood tests, urine tests, and swab tests, to detect the presence of a pathogen. These tests are used to diagnose a wide range of infectious diseases, including HIV, hepatitis, and tuberculosis. The Infectious Disease Testing market is driven by the increasing prevalence of infectious diseases, the growing demand for rapid and accurate diagnosis, and the development of new technologies. Companies in this market are developing innovative tests and technologies to improve the accuracy and speed of diagnosis. Some of the major companies in the Infectious Disease Testing market include Abbott Laboratories, Becton Dickinson, Cepheid, Hologic, and Roche Diagnostics. These companies are investing in research and development to develop new tests and technologies to improve the accuracy and speed of diagnosis. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.